Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2014 3
2015 4
2016 2
2017 2
2018 4
2019 2
2020 5
2021 5
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
[Diabetes and women, why are we different?].
Pérez Unanua MP, López Simarro F, Novillo López CI, Olivares Loro AG, Yáñez Freire S. Pérez Unanua MP, et al. Among authors: lopez simarro f. Semergen. 2023 Dec 4;50(2):102138. doi: 10.1016/j.semerg.2023.102138. Online ahead of print. Semergen. 2023. PMID: 38052103 Review. Spanish.
[Vulnerability and social determinants in diabetes].
Hernández-Teixidó C, López-Simarro F, Arranz Martínez E, Escobar Lavado FJ, Miravet Jiménez S. Hernández-Teixidó C, et al. Among authors: lopez simarro f. Semergen. 2023 Nov-Dec;49(8):102044. doi: 10.1016/j.semerg.2023.102044. Epub 2023 Jul 25. Semergen. 2023. PMID: 37481793 Review. Spanish.
[Update on the use of insulins for the primary care physician].
López-Simarro F, Cols-Sagarra C, Mediavilla Bravo JJ, Cañís-Olivé J, Hernández-Teixidó C, González Mohíno Loro MB. López-Simarro F, et al. Semergen. 2022 Jan-Feb;48(1):54-62. doi: 10.1016/j.semerg.2021.04.011. Epub 2021 Jul 12. Semergen. 2022. PMID: 34266759 Review. Spanish.
[Prevention and treatment of infectious diseases in diabetic patients].
López-Simarro F, Redondo Margüello E, Mediavilla Bravo JJ, Soriano Llora T, Iturralde Iriso J, Hormigo Pozo A. López-Simarro F, et al. Semergen. 2019 Mar;45(2):117-127. doi: 10.1016/j.semerg.2018.07.007. Epub 2018 Dec 20. Semergen. 2019. PMID: 30580897 Review. Spanish.
[Consensus document on the treatment of dyslipidemia in diabetes].
Hormigo-Pozo A, Mancera-Romero J, Perez-Unanua MP, Alonso-Fernandez M, Lopez-Simarro F, Mediavilla-Bravo JJ; Grupo de Trabajo de Diabetes de la Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Hormigo-Pozo A, et al. Among authors: lopez simarro f. Semergen. 2015 Mar;41(2):89-98. doi: 10.1016/j.semerg.2014.11.007. Epub 2014 Dec 18. Semergen. 2015. PMID: 25533449 Spanish.
100 years of the commercialization of insulin: A race yet to end.
Arranz Martínez E, Miravet Jiménez S, López Simarro F. Arranz Martínez E, et al. Among authors: lopez simarro f. Med Clin (Barc). 2023 Mar 24;160(6):268-274. doi: 10.1016/j.medcli.2022.11.005. Epub 2022 Dec 5. Med Clin (Barc). 2023. PMID: 36481116 English, Spanish. No abstract available.
The importance of the cut-off point for considering good adherence in diabetes.
Escribano-Serrano J, Michán-Doña A, López-Simarro F. Escribano-Serrano J, et al. Among authors: lopez simarro f. Med Clin (Barc). 2020 Nov 27;155(10):467-468. doi: 10.1016/j.medcli.2019.07.028. Epub 2020 Mar 17. Med Clin (Barc). 2020. PMID: 32197863 English, Spanish. No abstract available.
28 results